PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\'s Hospital, Harvard Medical School, Boston, USA. jklin@bwh.harvard.edu.\', \'Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. jklin@bwh.harvard.edu.\', \'Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\'s Hospital, Harvard Medical School, Boston, USA.\', \'Mass General Brigham Research Information Science and Computing, Boston, MA, USA.\', \'Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s40265-020-01424-7
?:doi
?:hasPublicationType
?:journal
  • Drugs
is ?:pmid of
?:pmid
?:pmid
  • 33151482
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.547
?:rankingScore_hIndex
  • 150
is ?:relation_isRelatedTo_publication of
?:title
  • Pharmacotherapy for Hospitalized Patients with COVID-19: Treatment Patterns by Disease Severity.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all